Jazz Pharmaceuticals (JAZZ) Work In Process (2010 - 2019)

Jazz Pharmaceuticals has reported Work In Process for 10 years, with the latest figure at $31.3 million in Q1 2019.

• For the quarter ending Q1 2019, Work In Process changed N/A year-over-year to $31.3 million; the trailing twelve-month figure through Mar 2019 stood at $31.3 million (changed N/A YoY), and the FY2018 full-year result was $26.0 million, up 65.91% from the prior year.
• Work In Process for Q1 2019 stood at $31.3 million, up from $26.0 million in the prior quarter.
• The five-year high for Work In Process was $31.3 million in Q1 2019, with the low at $11.8 million in Q4 2015.
• Average Work In Process over 5 years is $20.8 million, with a median of $20.0 million recorded in 2017.
• Year-over-year, Work In Process fell 16.04% in 2017 and jumped 65.91% in 2018.
• Tracing JAZZ's Work In Process over 5 years: stood at $11.8 million in 2015, then surged by 57.9% to $18.7 million in 2016, then slipped by 16.04% to $15.7 million in 2017, then surged by 65.91% to $26.0 million in 2018, then advanced by 20.05% to $31.3 million in 2019.
• The last three Work In Process figures came in at $31.3 million (Q1 2019), $26.0 million (Q4 2018), and $24.0 million (Q2 2018), per Business Quant data.

Peer Comparison